Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study

BACKGROUND: The detection rate of methylated Septin9 (mSEPT9) in colorectal cancer (CRC) is varied greatly across the studies. This study aimed to evaluate the diagnostic ability of mSEPT9 in CRC, and compare the diagnostic efficacy with fecal immunochemical test (FIT). METHODS: 326 subjects from fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Dong-cheng, Zhang, Qi-fang, Li, Li, Luo, Xian-ke, Liang, Bin, Lu, Yi-han, Hu, Bang-li, Jiang, Hai-xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097435/
https://www.ncbi.nlm.nih.gov/pubmed/35546391
http://dx.doi.org/10.1186/s12876-022-02313-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097435/
https://www.ncbi.nlm.nih.gov/pubmed/35546391
http://dx.doi.org/10.1186/s12876-022-02313-x

Ejemplares similares